Hubei Kangyuan Pharmaceutical Co., Ltd. is a national high-tech enterprise integrating R&D, production and sales. Its development predecessor was Ezhou Pharmaceutical Factory. It was founded in 1955. After half a century of operation and experience accumulation, it has relatively good quality in China. High popularity.

The company's production base is located in Gedian Economic Development Zone, Ezhou City, Hubei Province. It covers an area of ​​more than 70 mu. It has a standard GMP factory building of more than 300 square meters and currently has nearly 300 employees. The company has currently produced 15,000 external plasters. The production capacity of 500 tons of gelatin products such as 10,000 tablets, donkey-hide gelatin, and 100 million bottles of syrup. The company built a new production base covering an area of ​​150 mu in the Big Health Industrial Park of Gedian Economic and Technological Development Zone in 2021. It is expected to be officially put into production in 2024. By then, 700 tons of glue, 500 million pieces of plaster, and 65 million bottles of syrup will be built. a modern pharmaceutical manufacturer.

During the years of production and operation, the company adheres to the business purpose of "quality first and creation of an honest brand", and has product brands such as "Xishan", "Guanyinge", and "Stayshu", and produces 9 dosage forms and 31 products. Focus on scientific and technological investment, independently developed and obtained four invention patents, nineteen utility model patents, and one design patent.

The company has always adhered to the corporate spirit of "people-oriented and continuous innovation", adhered to the business philosophy of "high quality, high speed, high quality and high efficiency", took human health as its responsibility, and was committed to improving modern people's lives and actively devoted to the great health. In the industry, we are willing to work together with our colleagues engaged in the pharmaceutical industry to achieve the great goal of "Healthy China".